Depleting PTOV1 sensitizes non-small cell lung cancer cells to chemotherapy through attenuating cancer stem cell traits
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-9966
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Depleting PTOV1 sensitizes non-small cell lung cancer cells to chemotherapy through attenuating cancer stem cell traits ; volume:38 ; number:1 ; day:6 ; month:8 ; year:2019 ; pages:1-14 ; date:12.2019
Journal of experimental & clinical cancer research ; 38, Heft 1 (6.8.2019), 1-14, 12.2019
- Creator
-
Wu, Zhiqiang
Liu, Zhuang
Jiang, Xiangli
Mi, Zeyun
Meng, Maobin
Wang, Hui
Zhao, Jinlin
Zheng, Boyu
Yuan, Zhiyong
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13046-019-1349-y
- URN
-
urn:nbn:de:101:1-2019122808484608517744
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:00 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Wu, Zhiqiang
- Liu, Zhuang
- Jiang, Xiangli
- Mi, Zeyun
- Meng, Maobin
- Wang, Hui
- Zhao, Jinlin
- Zheng, Boyu
- Yuan, Zhiyong
- SpringerLink (Online service)
Other Objects (12)
Increased glutamine anabolism sensitizes non-small cell lung cancer to gefitinib treatment
MiR-1244 sensitizes the resistance of non-small cell lung cancer A549 cell to cisplatin
Methylsulfonylmethane sensitizes endometrial cancer cells to doxorubicin
Albendazole sensitizes cancer cells to ionizing radiation
FK228 sensitizes radioresistant small cell lung cancer cells to radiation
Letrozole sensitizes breast cancer cells to ionizing radiation
HMGN1 loss sensitizes lung cancer cells to chemotherapy
ALDH1A inhibition sensitizes colon cancer cells to chemotherapy
Non-small cell lung cancer treatment
Non-small cell lung cancer treatment
Non-small cell lung cancer treatment
N-Acetyl-Glucosamine Sensitizes Non-Small Cell Lung Cancer Cells to TRAIL-Induced Apoptosis by Activating Death Receptor 5
Increased glutamine anabolism sensitizes non-small cell lung cancer to gefitinib treatment
MiR-1244 sensitizes the resistance of non-small cell lung cancer A549 cell to cisplatin
Methylsulfonylmethane sensitizes endometrial cancer cells to doxorubicin
Albendazole sensitizes cancer cells to ionizing radiation
FK228 sensitizes radioresistant small cell lung cancer cells to radiation
Letrozole sensitizes breast cancer cells to ionizing radiation
HMGN1 loss sensitizes lung cancer cells to chemotherapy
ALDH1A inhibition sensitizes colon cancer cells to chemotherapy
Non-small cell lung cancer treatment
Non-small cell lung cancer treatment
Non-small cell lung cancer treatment
N-Acetyl-Glucosamine Sensitizes Non-Small Cell Lung Cancer Cells to TRAIL-Induced Apoptosis by Activating Death Receptor 5
Increased glutamine anabolism sensitizes non-small cell lung cancer to gefitinib treatment
MiR-1244 sensitizes the resistance of non-small cell lung cancer A549 cell to cisplatin
Methylsulfonylmethane sensitizes endometrial cancer cells to doxorubicin
Albendazole sensitizes cancer cells to ionizing radiation
FK228 sensitizes radioresistant small cell lung cancer cells to radiation
Letrozole sensitizes breast cancer cells to ionizing radiation
HMGN1 loss sensitizes lung cancer cells to chemotherapy
ALDH1A inhibition sensitizes colon cancer cells to chemotherapy
Non-small cell lung cancer treatment
Non-small cell lung cancer treatment
Non-small cell lung cancer treatment